Clinical Observation In Treating Chronic Colitis The "Spleen-Kidney Yang Vacuity" By Kui-Jie-Ling Ⅱ Granule And The Change Of IL-16, IL17

Objective:Observe kui-jie-ling-2 against chronic colitis patients for clinical curative effect. Observation before treating patients with chronic colitis serum IL-16, IL-17 variationsMethod:60 patients with chronic colitis patients were randomly divided into the treatment group and control group, The treatment group use kui-jie-ling-2 treatment the control group use SASP treatment. DalLy 3,4 weeks for a course, generally take 2 treatment. Observe clinical effectiveness and group 2 patients had before and after the treatment IL-16, IL-17 changes.ResuIts:Kui-jie-ling-2 treatment for 90%, efficient and chronic colitis than control group; The symptoms of the disease in treatment group than in control group, the improving function of significant difference between the two groups (p<0.05). The treatment group serum IL-16, IL-17 obviously lower than the control group, there are significant differences (p<0.05).Conclusion:kui-jie-ling-2 treatment for chronic colitis SASP clinically superior. Kui-jie-ling-2 can make patients with chronic colitis serum IL-16, IL-17 reduced significantly, and the related with intestinal inflammation reduce disappear.